Portolan Capital Management’s Imperva, Inc. IMPV Stock Holding History

Portolan Capital Management’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-27,292	Closed	-$1.05M	–	151
2016 Q4	$1.05M	Sell	27,292 -18,366	-40%	-$746K	0.14%	115
2016 Q3	$2.45M	Buy	+45,658	New	+$2.12M	0.34%	88
2014 Q3	–	Sell	-51,327	Closed	-$1.34M	–	132
2014 Q2	$1.34M	Buy	+51,327	New	+$1.33M	0.29%	100

Other funds holding IMPV

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Portolan Capital Management's IMPV Position: Q1 2017 in Review

Portolan Capital Management sold out of Imperva, Inc. (IMPV) in Q1 2017, closing a stake of 27,292 shares — an estimated $1.05M sold.

Portolan Capital Management first reported a position in IMPV in Q2 2014 and held it in 3 quarters. The position peaked at $2.45M in Q3 2016. 182 funds tracked by Wall St. Rank hold IMPV as of Q1 2017.

Portolan Capital Management reported no remaining Imperva, Inc. position as of Q1 2017 after selling out during the quarter.
Portolan Capital Management sold 27,292 Imperva, Inc. shares in Q1 2017, an estimated $1.05M.
Portolan Capital Management first reported a position in Imperva, Inc. in Q2 2014 and held it in 3 quarters.
Portolan Capital Management's Imperva, Inc. position peaked at $2.45M in Q3 2016.
182 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2017.

Based on Portolan Capital Management's 13F filing for Q1 2017, filed 15 May 2017.